Jean-pierre P. Bayley
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Genetic, cellular, and environmental factors influencing tumourigenesis in carriers of succinate dehydrogenase germline mutations.
Journal: Endocrine-related cancer
Published: May 31, 2026
Pilot study: transduction of primary paraganglioma chromaffin tumour cells with inducible c-MYC drives cell proliferation.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: March 25, 2026
Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 18, 2026
Optimal Screening for Hereditary Head and Neck Paraganglioma in Asymptomatic SDHx Variant Carriers in the Netherlands.
Journal: Journal of neurological surgery. Part B, Skull base
Published: November 23, 2023
Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas.
Journal: PloS one
Published: June 02, 2022
Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes.
Journal: Genes
Published: April 11, 2022
SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma.
Journal: Journal of medical genetics
Published: December 19, 2020
Advances in paraganglioma-pheochromocytoma cell lines and xenografts.
Journal: Endocrine-related cancer
Published: September 21, 2020
Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 25, 2020
Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
Journal: Journal of medical genetics
Published: April 09, 2019
Last Updated: 09/26/2026